Head to head
MEDVi vs Eden
What each one charges a month, which pharmacy each will name, and where each will treat you — read off their own sites, not their marketing.
Both sell compounded tirzepatide, where our ranking places MEDVi at #105 and Eden at #79 — on the criteria we publish.
What each actually charges
A blank means that provider does not sell that compound at all. Prices are the real month-to-month figure, not a prepay or first-month rate.
| Compound | ME MEDVi |  |
|---|---|---|
| Tirzepatide | $199/mo | $298/mo |
| Semaglutide | $166/mo | $198/mo |
| Sermorelin | Doesn't sell it | Not published |
| NAD+ | Doesn't sell it | $84/mo+ |
| Glutathione | Doesn't sell it | $95/mo+ |
| Pharmacy named | Not disclosed | Not disclosed |
MEDVi checked August 2026; Eden checked August 2026.
Who each one suits
Good fit if you want one company selling both compounded tirzepatide and compounded semaglutide, with a headline price for each published directly on its site.
The catch: FDA issued MEDVi, LLC a warning letter (MARCS-CMS 721455, February 20, 2026, Center for Drug Evaluation and Research) — the same date, office, and "identifies '[name]' on the pictured label, suggesting [name] is the compounder when in fact it is not" template already documented here for a peer provider, addressed to MEDVi's own registered Delaware corporate address. Separately, outside investigative journalism (Futurism; Drug Discovery Trends) previously reported that MEDVi's advertising used fabricated physician names in ad creative; a live check of MEDVi's current core site (2026-08-03) found no named, invented physicians anywhere on its site today, though this was not an exhaustive sweep of every historical ad. Neither finding disqualifies MEDVi on its own, but both are on the record here.
Good fit if you want one company selling both compounded tirzepatide and compounded sermorelin, rather than shopping separate providers for each.
The catch: Neither the $199/mo tirzepatide price nor the site-wide "Compounded semaglutide for $99/mo" banner that follows a reader across every page of the site mentions, next to the number itself, that a separate Eden Membership is required to buy at all — that fact lives only in a footnote below the price grid: "An active Eden Membership is required ($39 for the first month, auto-renews at $99/month thereafter). Medication is not available without a membership." Stacking that membership onto the medication price makes the true standing monthly cost $298 for tirzepatide and $198 for semaglutide — roughly 50% and 100% higher than the number that actually gets the click. Eden's own Terms of Service confirm the same $39/$99 structure a second time, so this isn't a stray footnote contradicted elsewhere — it's the real price, just never placed next to the one advertised loudest.
Where each one will treat you
MEDVi
No states-served list or exclusion list was found.
Eden
"All 50 states," per Eden's own GLP-1 treatment page: "We are currently able to serve GLP-1 programs to all 50 states." Its Terms of Service's California-resident disclosure section independently confirms the same membership terms apply nationwide. No exclusion list is published anywhere on the site.
Ready to start with one?
Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.